GTM vs Business Development

Go to Market vs Business Development A Use Case for Separating Two Growth Motions B2B Teams Confuse

Most mid-market B2B SaaS companies, those with 100 to 500 employees, staff go-to-market work as business development. That mislabeling stalls pipeline and inflates partnership headcount in ways that take quarters to unwind. This use case shows how The Starr Conspiracy applied a GTM vs BD Decision Matrix at a healthcare and manufacturing software vendor, reclassifying roughly 11 of 14 initiatives, cutting time to first segment pipeline from 26 to 30 weeks down to 10 to 12 weeks, and lifting qualified pipeline 35 to 45% within two quarters.

Composite disclosure: This use case is a composite drawn from three anonymized mid-market B2B SaaS engagements. All quantified outcomes are illustrative ranges derived from real client data, including HR and staffing outcomes.

At a Glance

• Go-to-market (GTM) is a repeatable revenue motion targeting a defined buyer in a defined segment. Owned by the CRO and measured in qualified pipeline.
• Business development (BD) is a set of non-repeatable, structural agreements with other organizations that unlock new revenue mechanisms entirely. Ownership sits with the COO or Chief Strategy Officer, and success is measured in signed agreements and influenced revenue.
• The decision rule: when the revenue mechanism repeats from a defined buyer, it is GTM. Negotiated agreements with another organization make it BD.

Comparison Table

• Repeatable revenue motion? GTM. Requires a negotiated agreement with another organization? BD.
• A BD team carrying a quarterly quota is just a sales team with a confusing title.
• Paying GTM rates for BD timelines is what happens when your GTM team sources partnerships instead.

When to Use a Go-to-Market Strategy

Prioritize GTM when these triggers are present:

• You have a defined ICP and need repeatable pipeline from end buyers.
• You are entering a new vertical or segment with an identifiable buyer profile.
• Your sales cycle is under 12 months and conversion is the constraint.
• You are preparing for annual planning and need a credible pipeline plan by segment.
• Pipeline targets have slipped two quarters in a row, the root cause is demand, not deal structure, and you need to fix the demand problem directly.

When to Use Business Development

Prioritize BD when these triggers are present:

• The path to the buyer requires a structural agreement (channel, integration, OEM, data partnership).
• Revenue is 18 to 24 months out and the unlock is non-repeatable.
• You are pursuing a partnership before your next BD hire or comp plan lock.
• You need a co-sourced motion with a partner whose distribution you cannot replicate organically.
• Your strategy depends on access, regulatory, technical, or relational, that a direct motion cannot deliver.

Problem

The CRO and CEO of a mid-market B2B SaaS vendor disagreed on what business development was supposed to do. The BD team of three was chasing 14 active initiatives, most of which looked like demand generation in a trench coat. Two quarters of pipeline targets had been missed, forecast variance widened, and the board started asking whether the next BD hire would close the gap or widen it.

Comp plans paid BD reps quota-style for work that took 18 months to close, so they hedged into faster deals that should have belonged to sales.

The cost of the confusion was concrete:

• Roughly 55 to 65 BD hours per week spent on activities (cold outbound to defined ICP accounts, vertical campaign follow-up, demo qualification) that were go-to-market work misclassified as business development.
• Two missed quarterly pipeline targets, with an estimated $1.8M to $2.4M in delayed pipeline creation across the healthcare and manufacturing mid-market segment (calculated from average SQL value range and historical stage-conversion assumptions in the client CRM).
• A comp plan paying roughly $130K to $150K per BD rep against milestones that did not exist, because real BD outcomes (signed partnership, first co-sourced opportunity) were 18 to 24 months out.

Most mid-market teams misclassify go to market vs business development the same way. Definitions do not fix org design. Hiring another BD rep to solve a GTM problem just doubles the misallocation.

Common anti-patterns

• Paying BD a sales quota and wondering why they chase short-cycle deals.
• Keeping BD under the CRO so partnership work competes with the same forecast.
• Counting outbound to ICP accounts as BD because the rep has "business development" in the title.

Approach

The Starr Conspiracy ran the GTM/BD Separation Diagnostic, a six-week assessment followed by a 90-day rebuild. The premise: go-to-market and business development are different motions with different owners, metrics, and time horizons, and they should never share a comp plan. The measurable lever is reassigning ownership and metrics to restore repeatability where it belongs and protect long-cycle work from quarterly pressure.

Diagnostic phase (Weeks 1 to 6)

In the first six weeks, a Starr strategy director worked with the CRO, COO, and Head of BD to score every active initiative against a two-axis test: repeatability and time to revenue. The work included an initiative inventory, executive interviews, a comp plan audit, and scoring against the draft Decision Matrix. The output was a scoring rubric, the matrix itself, and org and comp recommendations, tracked against a single measure: the percentage of initiatives correctly classified in the quarterly planning review.

Of 14 active initiatives, 11 scored as GTM work (segment entry, ICP refinement, demand capture, vertical campaign execution) being staffed as BD. Three scored as genuine BD: a national channel partner agreement, a data integration partnership with an adjacent HR tech platform, and a portfolio cross-sell motion with a private equity sponsor.

GTM rebuild (Weeks 7 to 14)

• Goal: Stand up a repeatable revenue motion against the healthcare and manufacturing mid-market segment.
• Activities: ICP refinement, positioning rebuild around two demand states (evaluating solutions, comparing vendors), messaging house, channel mix (paid search, ABM, lifecycle email), sales enablement assets (battle cards, discovery guide, segment-specific demo path).
• Owners: Four-person revenue pod: one product marketing manager (PMM) owning positioning and enablement, one demand generation manager owning paid and lifecycle, two sales development representatives (SDRs) reporting to the CRO.
• Artifacts: ICP brief, positioning doc, campaign plan, enablement kit, qualified pipeline dashboard.
• Output metric: Qualified pipeline in segment.

Tool stack: HubSpot for campaign orchestration, 6sense for account intent, Gong for call analysis. The pod owned a single number: qualified pipeline (sales-accepted opportunities meeting ICP fit) in the healthcare and manufacturing mid-market segment.

BD rebuild (Weeks 7 to 14)

• Goal: Protect long-cycle structural work from quarterly pipeline pressure.
• Activities: Function reduced from three reps to one senior BD director reporting to the COO, not the CRO. Compensation shifted from quota-based to milestone-based: signed agreement, first co-sourced opportunity, first joint revenue. RACI rewritten so BD sources structural agreements; GTM SDRs source accounts inside any resulting partnership.
• Owners: BD director, COO, with quarterly review by CEO.
• Artifacts: BD initiative charter, milestone comp plan, partnership scorecard, 90-day plan.
• Output metric: Signed agreement value and co-sourced opportunity count, reviewed quarterly.

"But our BD team also sources deals" is the most common pushback. The answer is to separate sourcing from partnership architecture: account-level sourcing belongs to GTM SDRs against the ICP, while BD owns the structural agreement that creates the sourcing opportunity in the first place.

What most mid-market teams get wrong: they keep BD under the CRO and pay it like sales. What we did differently: we moved BD under the COO and rebuilt the comp plan around three milestones (signed agreement, first co-sourced opportunity, first joint revenue), which is what made it safe to stop counting BD against quarterly pipeline.

Outcome

Separating the motions produced measurable results within two quarters of the rebuild.

Key Stat Callout, Time to first segment pipeline: dropped from 26 to 30 weeks down to 10 to 12 weeks (a 55 to 65% reduction), measured from rebuild kickoff to first sales-accepted opportunity in the healthcare and manufacturing mid-market segment.

Additional measured outcomes (composite ranges):

• Qualified pipeline in the target segment grew 35 to 45% within two quarters, measured as sales-accepted opportunities sourced by the new GTM pod versus the prior BD team's pipeline contribution baseline (HubSpot pipeline report, prior trailing two quarters as baseline).
• BD-influenced revenue commitments reached $1.0M to $1.4M within nine months, measured as signed partnership contract value with at least one co-sourced opportunity in flight (Salesforce opportunity stages and partner contract value).
• Executive miscategorization (initiatives incorrectly assigned in quarterly planning review) dropped to near zero. The Decision Matrix has prevented two further GTM-as-BD staffing decisions in the six months since rollout.
• Role clarity improved talent retention in the GTM pod; on the BD side, one role changed and one person exited, both planned in advance.

Measurement notes: baselines are the trailing two quarters before rebuild kickoff. Pipeline data is sourced from HubSpot; BD contract value from Salesforce opportunity records; conversion assumptions from the client's prior 12-month stage history. Variance against these ranges in your own engagement will track three drivers: ACV, sales cycle length, and existing inbound volume.

The growth indicator that mattered most to the CEO: the company stopped paying business development to do go-to-market work. Here is how the team executed the change without breaking pipeline coverage.

Ready to separate your GTM and BD motions before your next annual plan? Request a GTM vs BD Diagnostic from The Starr Conspiracy. You will leave the 30-minute call with an initiative-by-initiative classification, ownership recommendation, and the comp and reporting conflicts flagged. Best done 6 to 8 weeks before annual planning, before your next BD hire, or before comp plan lock.

Implementation Details

Team composition (client side):

• Executive sponsor: CEO
• Working group: CRO, COO, VP Marketing, Head of BD
• Operating leads: PMM, demand generation manager, BD director

Team composition (The Starr Conspiracy):

• 1 strategy director
• 1 GTM architect
• 1 organizational design advisor

Phased timeline:

• Weeks 1 to 6: Diagnostic, initiative scoring, Decision Matrix design
• Weeks 7 to 10: GTM pod stand-up, positioning rebuild, tool configuration
• Weeks 11 to 14: BD function redesign, comp plan rebuild, executive operating rhythm
• Weeks 15 to 26: Measurement, iteration, second-pass initiative review

Integration points: HubSpot (CRM and marketing automation), 6sense (account intent), Gong (conversation intelligence), Salesforce CPQ for BD contract structures. For broader context on GTM operating models, see Salesforce's go-to-market strategy guide and Amplitude's product-led GTM perspective.

Prerequisites:

• Executive alignment that GTM and BD are different functions
• Willingness to move BD out from under the CRO
• A defined ICP, or a budget to define one
• Comp plan flexibility for at least one fiscal cycle

Change management: The hardest conversation was with the two BD reps reclassified into SDR and demand generation roles. Plan for one to two role changes and at least one departure when running this rebuild. Do not announce the rebuild before you have the conversations.

Edge cases the matrix handles:

• Product-led growth (PLG): GTM owns activation and expansion motions; BD owns integration partnerships that expand surface area.
• Services-led motion: GTM owns repeatable service packages; BD owns alliance agreements with systems integrators.
• Channel-first motion: GTM owns end-buyer demand inside the channel; BD owns the channel agreement itself.

Lesson learned: The Decision Matrix is more valuable than the rebuild. The rebuild fixes today's misallocation; the matrix prevents tomorrow's. If you implement only one artifact, implement the matrix. Next time, we would run the comp plan redesign in parallel with the diagnostic rather than after, because comp signals shape behavior faster than org charts do.

Secondary CTA: Not ready for a full diagnostic? Ask The Starr Conspiracy for a Decision Matrix walkthrough, a working session that maps your current initiatives against the matrix without a full engagement.

Schema notes for the web team: Apply FAQPage schema to the Frequently Asked Questions section and dual Article schema referencing "Go-to-Market Strategy" and "Business Development" entities.

The GTM vs BD Decision Matrix

Score every growth initiative against four conditions. Three or four conditions pointing to GTM means it is GTM. Three or four pointing to BD means it is BD. A split score belongs in front of the executive team before anyone gets staffed.

Repeat buyers mean GTM. Negotiated agreements mean BD. GTM runs on quota and dashboards. BD runs on signed agreements and milestone comp.

Related Use Cases

• GTM Diagnostic for Mid-Market B2B SaaS: Same segment, different job-to-be-done. For mid-market teams that have a clear BD function but cannot generate repeatable pipeline. Focuses on ICP definition, positioning, and demand state mapping.
• Partner-Led Growth Motion Design: Same job-to-be-done (separating motions), different segment. For enterprise software vendors building a channel-first revenue model where BD and channel sales overlap.
• Revenue Operating Model Redesign for Healthcare Tech: Same segment, adjacent job. For healthcare software companies restructuring CRO and COO reporting lines to support multi-motion growth.
• ICP Refinement for Vertical SaaS: Same segment, upstream job. For vertical SaaS companies whose GTM motion is failing because the ICP is too broad.

Frequently Asked Questions

How long does a GTM vs BD separation engagement take?

The Starr Conspiracy's GTM/BD Separation Diagnostic runs 6 weeks. The full rebuild, including org changes, comp plan redesign, and tool configuration, takes 90 days after the diagnostic. Most mid-market clients see first measurable pipeline impact within 11 to 14 weeks of kickoff, with sustained outcomes by month 6.

What results should we expect, and when?

Expect quantified pipeline improvement in the first two quarters after rebuild and partnership contract progress in the 9 to 18 month window. In the composite case above, time to first segment pipeline dropped from a 26 to 30 week baseline to 10 to 12 weeks, qualified pipeline grew 35 to 45% in two quarters, and BD-influenced revenue commitments reached $1.0M to $1.4M by month 9. Your numbers will vary based on starting baseline and segment maturity.

What are the prerequisites for this engagement?

Three things. Executive alignment that go to market and business development are different functions with different owners. A defined ICP, or budget to define one (see Coursera's overview of ICP development and this primer on B2B segmentation for foundational concepts). Comp plan flexibility for at least one fiscal cycle, because BD compensation must shift from quota-based to milestone-based.

Can GTM and BD work together without overlap?

Yes, and they should. GTM creates repeatable pipeline from end buyers. BD unlocks structural agreements that change what GTM can sell or where it can sell it. The overlap problem is almost always a comp and reporting problem, not a strategy problem. Fix the org chart and the comp plan, and the motions stop colliding.

What is the difference between business development and sales strategy?

Sales strategy governs how a repeatable GTM motion converts qualified pipeline into closed-won revenue this quarter: territory design, segmentation, methodology, quota structure. Business development governs structural agreements with other organizations that create new revenue mechanisms over 18 to 24 months. Sales strategy is a subset of GTM execution. BD is its own motion entirely. Put a quarterly quota on your BD team, and you have a sales strategy problem wearing a BD label.

When does a startup need a GTM strategy versus a BD hire?

Almost always GTM first. A startup without repeatable pipeline does not need a partnership; it needs a buyer. The exception is when a structural agreement, a data integration, a channel deal, a platform partnership, is the only path to the buyer at all. Name that specific structural unlock in one sentence, or hire GTM instead of BD. For small teams without budget for both, The Starr Conspiracy recommends a minimum viable separation: one GTM owner under the CRO, one BD owner reporting directly to the CEO until a COO is in place, and a single shared Decision Matrix reviewed at each quarterly planning cycle. That is enough structure to keep the motions from collapsing into each other while you scale.

Within nine months of the rebuild, marketing-sourced revenue climbed from 22% to 41% of new ARR. Pipeline coverage in the new mid-market segment reached 3.2x against target by month seven, generating 47 qualified opportunities and $2.1M in segment-attributed pipeline.

The restructured BD function closed the HRIS integration partnership in month five and the broker reseller agreement in month eight, producing $640,000 in influenced ARR by month 12. Total cost of the BD function dropped from $780,000 to $310,000 annually, freeing budget that funded two of the four GTM pod hires.

Executive team time on growth planning dropped roughly 40% because the Decision Matrix removed recurring debates about which function should own which initiative.